| Ytd | -3.95% | |
| 1y | 13.10% |
| Open | 29.00 | Prev Close | 29.60 | Low | 27.81 | High | 29.37 | Mkt Cap | 234.00M |
| Vol | 181.63K | Avg Vol | 97.46K | EPS | 1.23 | P/E | 22.74 | Forward P/E | 46.97 |
| Beta | 0.26 | Short Ratio | 2.66 | Inst. Own | 36.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 40.95 | 200-d Avg | 31.35 | 1yr Est | 33.00 |
Electromed's direct-to-patient model, broad payer coverage, and disciplined sales execution support
Gainers Biohaven (NYSE:BHVN) shares increased by 16.5% to $16.75 during Wednesday's regular ses
Lake Street analyst Benjamin Haynor maintains Electromed (AMEX:ELMD) with a Buy and raises the pr
Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
Electromed, Inc. (ELMD) came out with quarterly earnings of $0.39 per share, beating the Zacks Conse
Electromed (AMEX:ELMD) held its fourth-quarter earnings conference call on Tuesday. Below is the com
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today
Electromed (AMEX:ELMD) reported quarterly earnings of $0.39 per share which beat the analyst consens
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Announces CEO's Planned Retirement.
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on A
LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help i
Electromed (ELMD) made it through our "Recent Price Strength" screen and could be a great choice for
If you are looking for stocks that are well positioned to maintain their recent uptrend, Electromed
Electromed is rated 'buy' due to accelerating growth, margin expansion, and a large underpenetrated
Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth i
GOLD, ELMD and TPR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2nd, 2026.
GOLD, ELMD, TPR, PLGO and CRGY have been added to the Zacks Rank #1 (Strong Buy) List on June 2nd, 2
Electromed (ELMD) is at a 52-week high, but can investors hope for more gains in the future? We take
GenAI is reshaping medical instruments as Electromed, Globus Medical and Intuitive Surgical navigate
Electromed, Inc. (ELMD) reached a significant support level, and could be a good pick for investors
Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the mark
Electromed (ELMD) could be a great choice for investors looking to make a profit from fundamentally
HCSG, ELMD, UMBF, SHEL and MTSI passed an efficiency screen based on turnover ratios, asset use and
Electromed (ELMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism abo
B. Riley Securities analyst Kyle Bauser maintains Electromed (AMEX:ELMD) with a Buy and raises th
Electromed (AMEX:ELMD) reported quarterly earnings of $0.35 per share which beat the analyst consens
Electromed (AMEX:ELMD) reported quarterly earnings of $0.32 per share which beat the analyst consens
Roth Capital analyst Kyle Bauser reiterates Electromed (AMEX:ELMD) with a Buy and raises the pric
Electromed (AMEX:ELMD) reported quarterly earnings of $0.25 per share which beat the analyst consens
Roth Capital analyst Kyle Bauser maintains Electromed (AMEX:ELMD) with a Buy and raises the price
Lake Street analyst Benjamin Haynor assumes Electromed (AMEX:ELMD) with a Buy rating and announce
Electromed (AMEX:ELMD) reported quarterly earnings of $0.25 per share which beat the analyst consens
Roth Capital analyst Kyle Bauser initiates coverage on Electromed (AMEX:ELMD) with a Buy rating a
Electromed (AMEX:ELMD) reported quarterly earnings of $0.21 per share which beat the analyst consens
B. Riley Securities analyst Kyle Bauser initiates coverage on Electromed (NYSE:ELMD) with a Buy r
Electromed (AMEX:ELMD) reported quarterly earnings of $0.22 per share which beat the analyst consens